Acelyrin Inc.

NASDAQ: SLRN · Real-Time Price · USD
2.27
0.00 (0.00%)
At close: May 20, 2025, 3:59 PM

Acelyrin Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-248.23M -381.64M -64.77M -41.84M
Depreciation & Amortization
-17.99M 115K n/a n/a
Stock-Based Compensation
44.96M 47.32M 4.05M 233K
Other Working Capital
-40.32M 17.64M -3.84M 10.51M
Other Non-Cash Items
-23.72M 112.42M -733K 25M
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
-77.35M 52.08M -67K 11.63M
Operating Cash Flow
-303.92M -169.71M -61.52M -4.98M
Capital Expenditures
-1.25M -12.29M n/a -25M
Cash Acquisitions
n/a 10.01M -83K -25M
Purchase of Investments
-827.8M -956.51M -175.97M n/a
Sales Maturities Of Investments
976.91M 511.06M 128.18M n/a
Other Investing Acitivies
7M -10M -47.79M -25M
Investing Cash Flow
154.87M -447.74M -47.87M -25M
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
5.39M -5.7M 10.29M 16K
Financial Cash Flow
5.39M 568.44M 274.26M 124.72M
Net Cash Flow
-143.66M -49.01M 164.87M 94.74M
Free Cash Flow
-305.17M -182M -61.52M -29.98M